DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 148 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14 | +16.7% | 1,108 | +28.8% | 0.00% | – |
Q2 2023 | $12 | +33.3% | 860 | +33.3% | 0.00% | – |
Q1 2023 | $9 | -100.0% | 645 | -73.0% | 0.00% | – |
Q4 2021 | $23,000 | -58.9% | 2,391 | +57.3% | 0.00% | – |
Q3 2021 | $56,000 | -9.7% | 1,520 | -11.6% | 0.00% | – |
Q2 2021 | $62,000 | +34.8% | 1,720 | +111.0% | 0.00% | – |
Q4 2020 | $46,000 | -45.9% | 815 | -60.9% | 0.00% | – |
Q1 2020 | $85,000 | -88.8% | 2,083 | -82.9% | 0.00% | -100.0% |
Q4 2019 | $758,000 | +897.4% | 12,184 | +438.2% | 0.00% | – |
Q3 2019 | $76,000 | – | 2,264 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |